Instrumento Inactivo

Otros idiomas Hi-Tech Pharmacal Co.

Acciones

US42840B1017

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Hi Tech Pharmacal : Akorn Completes Acquisition of Hi-Tech Pharmacal	17/04/14
Hi Tech Pharmacal : Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition	15/04/14
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014	11/03/14
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)	23/01/14
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation	26/12/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013	10/12/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2013	05/09/13
Hi-Tech Pharmacal Co. : HI-TECH PHARMACAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Hi-Tech Pharmacal Co., Inc. Following Announcement of Proposed Sale of Company to Akorn, Inc.	29/08/13
Hi-Tech Pharmacal Co. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hi-Tech Pharmacal Co., Inc. Shareholders	28/08/13
Hi-Tech Pharmacal Co. : Ryan & Maniskas, LLP Announces Investigation of Hi-Tech Pharmacal Co., Inc.	28/08/13
Hi-Tech Pharmacal Co. : Akorn to Acquire Hi-Tech Pharmacal for $640 Million	27/08/13
Hi-Tech Pharmacal Co. : Health Care Products Division of Hi-Tech Pharmacal Receives FDA Warning Letter Related to Labeling Statements on Certain OTC Products	24/07/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 9, 2013	03/07/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	09/05/13
Hi-Tech Pharmacal Co. : ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO	30/04/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference	29/04/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013	07/03/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 7, 2013	04/03/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets' Healthcare Conference	27/02/13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Oppenheimer 23rd Annual Healthcare Conference	11/12/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Hi-Tech Pharmacal Co.

Acciones

US42840B1017

Otros idiomas

Filtros